Willow Biosciences Touts Strong Q3 Results, Continues Its Focus On Biosynthetically Produced Cannabinoids
Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF) released its third-quarter financial and operating results Monday, revealing it has ended the quarter in a strong financial position, with approximately $35.7 million i
